Rocco Piazza

5.8k total citations
137 papers, 2.2k citations indexed

About

Rocco Piazza is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Rocco Piazza has authored 137 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Hematology, 47 papers in Molecular Biology and 40 papers in Genetics. Recurrent topics in Rocco Piazza's work include Chronic Myeloid Leukemia Treatments (38 papers), Chronic Lymphocytic Leukemia Research (29 papers) and Acute Myeloid Leukemia Research (17 papers). Rocco Piazza is often cited by papers focused on Chronic Myeloid Leukemia Treatments (38 papers), Chronic Lymphocytic Leukemia Research (29 papers) and Acute Myeloid Leukemia Research (17 papers). Rocco Piazza collaborates with scholars based in Italy, United States and Germany. Rocco Piazza's co-authors include Carlo Gambacorti‐Passerini, Léonardo Scapozza, Vera Magistroni, Sara Redaelli, Roberta Rostagno, Annamaria Galietta, Rosalind H. Gunby, Luca Mologni, Alessandra Pirola and Monica Ceccon and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Rocco Piazza

127 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rocco Piazza Italy	26	874	761	659	447	407	137	2.2k
Jean‐Claude Chomel France	22	774 0.9×	672 0.9×	619 0.9×	305 0.7×	271 0.7×	75	1.8k
Robert S. Ohgami United States	24	939 1.1×	676 0.9×	605 0.9×	677 1.5×	168 0.4×	92	2.8k
Cristina Papayannidis Italy	26	1.4k 1.6×	1.0k 1.3×	508 0.8×	882 2.0×	194 0.5×	160	2.7k
Edgar Jost Germany	23	551 0.6×	1.0k 1.3×	318 0.5×	392 0.9×	83 0.2×	100	1.8k
Hirotaka Matsui Japan	28	780 0.9×	1.4k 1.9×	279 0.4×	368 0.8×	96 0.2×	116	2.3k
Anna Teresa Maiolo Italy	25	879 1.0×	1.0k 1.3×	533 0.8×	499 1.1×	193 0.5×	86	2.3k
K Kaushansky United States	18	919 1.1×	663 0.9×	340 0.5×	394 0.9×	271 0.7×	24	2.2k
Christopher Ocampo United States	17	862 1.0×	929 1.2×	288 0.4×	578 1.3×	61 0.1×	33	2.2k
Hirokazu Ikeda Japan	20	609 0.7×	738 1.0×	412 0.6×	252 0.6×	239 0.6×	70	2.1k
Mark Blick United States	28	830 0.9×	1.0k 1.4×	589 0.9×	999 2.2×	210 0.5×	55	2.8k

Countries citing papers authored by Rocco Piazza

Since Specialization

Citations

This map shows the geographic impact of Rocco Piazza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rocco Piazza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rocco Piazza more than expected).

Fields of papers citing papers by Rocco Piazza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rocco Piazza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rocco Piazza. The network helps show where Rocco Piazza may publish in the future.

Co-authorship network of co-authors of Rocco Piazza

This figure shows the co-authorship network connecting the top 25 collaborators of Rocco Piazza. A scholar is included among the top collaborators of Rocco Piazza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rocco Piazza. Rocco Piazza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mikulak, Joanna, Rocco Piazza, Domenico Vitobello, et al.. (2025). Immune evasion mechanisms in early-stage I high-grade serous ovarian carcinoma: insights into regulatory T cell dynamics. Cell Death and Disease. 16(1). 229–229. 2 indexed citations

Ramazzotti, Daniele, et al.. (2024). Control-FREEC viewer: a tool for the visualization and exploration of copy number variation data. BMC Bioinformatics. 25(1). 72–72. 1 indexed citations

Mauri, Mario, Francesca Raimondo, Laura Dioni, et al.. (2024). ActivinA modulates B-acute lymphoblastic leukaemia cell communication and survival by inducing extracellular vesicles production. Scientific Reports. 14(1). 16083–16083. 2 indexed citations

Bettini, Laura Rachele, Grazia Fazio, Claudia Saitta, et al.. (2024). Diverse mechanisms of leukemogenesis associated with PAX5 germline mutation. Leukemia. 38(11). 2479–2482. 3 indexed citations

Gabrielli, Martina, Florence Julien‐Marsollier, Valérie Faivre, et al.. (2024). Human Umbilical Cord-Mesenchymal Stem Cells Promote Extracellular Matrix Remodeling in Microglia. Cells. 13(19). 1665–1665. 2 indexed citations

Mauri, Mario, Giovanni Paolo Maria Zambrotta, Daniele Ramazzotti, et al.. (2023). DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients. HemaSphere. 7(3). e852–e852. 2 indexed citations

Fontana, Diletta, Fabrizio Angaroni, De Luca, et al.. (2023). Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients. Nature Communications. 14(1). 5982–5982. 2 indexed citations

Tettamanti, Sarah, Stefania Galimberti, Rocco Piazza, et al.. (2023). Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the Acute Myeloid Leukemia burden. Blood. 141(21). 2587–2598. 27 indexed citations

Ramazzotti, Daniele, Fabrizio Angaroni, Davide Maspero, et al.. (2022). Large-scale analysis of SARS-CoV-2 synonymous mutations reveals the adaptation to the human codon usage during the virus evolution. Virus Evolution. 8(1). veac026–veac026. 17 indexed citations

10.

Borrego, Andrea, Francesca Colombo, José Ricardo Jensen, et al.. (2022). Pycard and BC017158 Candidate Genes of Irm1 Locus Modulate Inflammasome Activation for IL-1β Production. Frontiers in Immunology. 13. 899569–899569. 3 indexed citations

11.

Diviccaro, Silvia, Rocco Piazza, Paola Brivio, et al.. (2022). Gut microbiota composition is altered in a preclinical model of type 1 diabetes mellitus: Influence on gut steroids, permeability, and cognitive abilities. Neuropharmacology. 226. 109405–109405. 13 indexed citations

12.

Aroldi, Andrea, Lorenza Borin, Luisa Verga, et al.. (2022). Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID‐19 vaccine: A single‐center prospective observational study (NCT05074706). SHILAP Revista de lepidopterología. 3(4). 1201–1208. 3 indexed citations

13.

Bruni, Elena, Matteo Cimino, Matteo Donadon, et al.. (2022). Intrahepatic CD69⁺Vδ1 T cells re-circulate in the blood of patients with metastatic colorectal cancer and limit tumor progression. Journal for ImmunoTherapy of Cancer. 10(7). e004579–e004579. 34 indexed citations

14.

Gambacorti‐Passerini, Carlo, Andrea Aroldi, Rocco Piazza, et al.. (2021). Transfusion of blood products derived from SARS-CoV-2+ donors to patients with hematological malignancies. Transfusion and Apheresis Science. 60(3). 103105–103105. 3 indexed citations

15.

Sharma, Geeta G., Mario Mauri, Diletta Fontana, et al.. (2021). Synergistic Drug Combinations Prevent Resistance in ALK+ Anaplastic Large Cell Lymphoma. Cancers. 13(17). 4422–4422. 10 indexed citations

16.

Angaroni, Fabrizio, Alex Graudenzi, Marco Rossignolo, et al.. (2020). An Optimal Control Framework for the Automated Design of Personalized Cancer Treatments. Frontiers in Bioengineering and Biotechnology. 8. 523–523. 16 indexed citations

17.

Redaelli, Sara, Monica Ceccon, Geeta G. Sharma, et al.. (2018). Lorlatinib Treatment Elicits Multiple On- and Off-Target Mechanisms of Resistance in ALK-Driven Cancer. Cancer Research. 78(24). 6866–6880. 61 indexed citations

18.

Ceccon, Monica, Luca Mologni, Giovanni De Giudici, et al.. (2014). Treatment Efficacy and Resistance Mechanisms Using the Second-Generation ALK Inhibitor AP26113 in Human NPM-ALK–Positive Anaplastic Large Cell Lymphoma. Molecular Cancer Research. 13(4). 775–783. 47 indexed citations

19.

Magistroni, Vera, Luca Mologni, James F. Reid, et al.. (2011). ERG Deregulation Induces PIM1 Over-Expression and Aneuploidy in Prostate Epithelial Cells. PLoS ONE. 6(11). e28162–e28162. 26 indexed citations

20.

Galietta, Annamaria, Rosalind H. Gunby, Sara Redaelli, et al.. (2007). NPM/ALK binds and phosphorylates the RNA/DNA binding protein PSF in anaplastic large cell lymphoma. Haematologica. 92. 48–49. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact